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ABSTRACT 
Aim To evaluate the effect of regional implementation of a preconception counselling 
resource into routine diabetes care on pregnancy planning indicators. 
Methods A preconception counselling DVD was distributed to women by diabetes care 
teams and general practices. Subsequently, in a prospective population-based study, 
pregnancy planning indicators were evaluated.  The post-DVD cohort (n=135), 
including a viewed-DVD subgroup (n=58), were compared with an historical cohort (pre-
DVD, n=114). Primary outcome was HbA1c at first diabetes-antenatal visit. Secondary 
outcomes included preconception folic acid consumption, planned pregnancy and 
HbA1c recorded in the 6 months preconception. 
Results Mean first visit HbA1c was lower post-DVD vs. pre-DVD: 7.5% vs. 7.8% [58.4 
vs. 61.8mmol/mol]; p=0.12), although not statistically significant. 53% and 20% of 
women with type 1 and 2 diabetes, respectively, viewed the DVD. The viewed-DVD 
subgroup were significantly more likely to have lower first visit HbA1c:  6.9% vs. 7.8% 
[52.1 vs. 61.8mmol/mol], p<0.001; planned pregnancy (88% vs. 59%, P<0.001); taken 
folic acid preconception (81% vs. 43%, P=0.001); and had HbA1c recorded 
preconception (88% vs. 53%, P<0.001) than the pre-DVD cohort.  
Conclusions Implementation of a preconception counselling resource was associated 
with improved pregnancy planning indicators.  Women with type 2 diabetes are difficult 
to reach. Greater awareness within primary care of the importance of preconception 
counselling among this population is needed.   
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Highlights 
• Pregnancy planning and pre-pregnancy care uptake is poor among women 
with diabetes 
• Poor preconception counselling is linked to poor pre-pregnancy care uptake 
• Implementation of a preconception counselling resource improved pregnancy 
planning  
• Women who engaged with the resource were better prepared for pregnancy 
• Women with type 2 diabetes, typically cared for in primary care, are hard to 
reach 
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INTRODUCTION 
Women with diabetes preceding pregnancy are at significant risk of adverse 
pregnancy outcomes when compared to the general maternity population, with higher 
rates of miscarriage, congenital malformations and stillbirth [1-7].  Planning pregnancy 
with the emphasis on optimizing glycemic control before conception reduces the risk 
of adverse outcomes [6-10]. All women with diabetes of childbearing potential should 
be counselled as to the risks associated with pregnancy and diabetes and of the 
benefits of planning for pregnancy. This ‘conversation’ with women, referred to as 
preconception counselling, should be incorporated regularly into routine diabetes 
outpatient visits and primary care consultations from adolescence according to 
national guidelines [11,12]. However, preconception counselling rates among women 
with diabetes remain low [13,14], with preconception counselling or contraception 
discussed with only 25% of women attending for annual review in one study [14].  
 
In distinction from preconception counselling, pre-pregnancy care (PPC) is targeted 
specifically at women who are preparing for pregnancy [15]. While the emphasis of 
PPC is on glycemic control, other key components include prescription of high dose 
folic acid preconception and review of medications to ensure women avoid potentially 
teratogenic drugs. Despite the known benefits of PPC in reducing adverse outcomes, 
attendance remains suboptimal [8,16]; in one recent study only 27% of pregnant 
women attended formal PPC services [8]. While many women with diabetes are aware 
of the need to plan for pregnancy, they are often not aware of the reasons why [17,18].  
To avoid unnecessary anxiety, women need to need to know why planning is important 
and must feel confident that they can effectively plan their pregnancies [18]. There is 
5 
 
a clear need to deliver accessible and appropriate information in relation to pregnancy 
planning.  
 
To address low preconception counselling rates among women with diabetes and the 
consequences associated with lack of pregnancy planning knowledge, the Women 
with Diabetes Project team developed an educational preconception counselling DVD 
[17,19], which was evaluated among 97 women with diabetes for effectiveness in 
changing knowledge and attitudes towards preconception care. e study. Findings 
demonstrated effectiveness in increasing knowledge and enhancing attitudes of 
women with diabetes to preconception care [20], suggested that the DVD was an 
appropriate educational tool for use as a pre-pregnancy counselling resource to 
prepare women with diabetes for pregnancy. Since 2010, the DVD has been adopted 
throughout Northern Ireland as a preconception counselling resource. The aim of the 
current study was to evaluate the effect of implementation of the resource into routine 
care on indicators of pregnancy planning in women with diabetes. Furthermore, given 
that the prior evaluation showed that the resource significantly improved attitudes of 
women toward PPC, we hypothesised that women who both received and viewed the 
DVD would be more likely to  plan for pregnancy resulting in significantly improved 
pregnancy planning indicators compared with women who conceived prior to 
implementation of the pre-pregnancy counselling resource. 
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METHODS 
This study is a prospective nationwide population based study across all five regional 
diabetes-antenatal clinics in Northern Ireland comparing pregnancy planning 
indicators in pre- and post-preconception counselling resource cohorts. Study 
participants were women with pre-gestational diabetes who delivered/were expected 
to deliver between February 2012 and January 2013 (post-DVD cohort), including a 
viewed-DVD subgroup, compared with an historical cohort from the same five clinics 
(pre-DVD comparison cohort from between 1st September 2009 and 31st August 2010) 
(Figure 1). The intervention was a preconception counselling DVD distributed by 
diabetes care teams and general practices to women with diabetes of child bearing 
potential. This study was designed as a service evaluation utilising historic audit data 
as a comparison cohort and therefore did not require approval from a Research Ethics 
Committee. Local approvals were obtained. 
 
Intervention development and implementation  
A preconception counselling DVD resource was systematically developed using a 
combined user and multi-professional advisory group approach as described 
previously [19]. In brief, the content and style of the resource were guided by 
qualitative focus groups with women and by a multi-professional advisory group. The 
resource was underpinned by the Expanded Health Belief Model [21], is of 45-minutes 
duration and focuses on the importance of planning for pregnancy and on essential 
pregnancy planning advice in the form of a pre-pregnancy checklist. The DVD 
resource is women centred, featuring eight women with diabetes sharing their views 
and experiences, alongside an evidence-based commentary.  The DVD has 3 parts: 
Part 1, “things you need to know”, encompassing  sections entitled ‘contraception’, 
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‘risks, ‘why plan’ and a ‘pre-pregnancy checklist’; Part 2 “things you might not know” 
encompassing sections entitled ‘support team’, ‘blood glucose targets, hypos and 
ketoacidosis’ and ‘diet’; and Part 3 “Things you may want to know!!” encompassing  
sections entitled ‘1st 2nd and 3rd trimester’, ‘Delivery’ and ‘Post-birth’.  
Between October and December 2010, 6029 DVDs were distributed via 
healthcare professionals to all women with diabetes of childbearing age and potential 
within their care (Figure 1). All diabetes care teams within the five health and social 
care trusts in Northern Ireland (NI) adopted the resource as a preconception 
counselling resource. In addition, all general practices in NI were invited to request 
DVDs for distribution to patients under their care to ensure that women with type 2 
diabetes, who did not attend secondary care, also received the resource.  In total 34% 
of general practices actively engaged with the distribution process, with the remaining 
practices sent a DVD for information and for use within their practice. Awareness of 
the DVD among women with diabetes was further enhanced by promotion of the 
resource at local meetings, a local press release and a Diabetes UK mail out which 
coincided with the DVD launch. Diabetes care teams and general practices distributed 
the DVDs as appropriate to the needs of their patients, with some mailing DVDs to all 
women of child-bearing potential and others choosing to give DVDs face to face in 
clinic. Prior to the implementation of the DVD resource into routine care, no other 
educational resources in relation to preconception counselling/care for women with 
diabetes were widely available in NI.    
A period of at least 5 months was allowed to elapse between distribution of the 
DVD resource and anticipated first conception for inclusion in the service evaluation. 
This time period allowed women who received the DVD from their healthcare 
professional the opportunity to view the resource and to take the necessary steps to 
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plan their pregnancies, including taking action to plan pregnancy (make lifestyle 
changes, attend PPC, commence folic acid and optimise blood glucose control). 
 
Study Population 
All women with diabetes preceding pregnancy (type 1 or type 2) who became pregnant 
after this period (first day of last menstrual period on or after 1st June 2011) and who 
attended one of the five joint diabetes-antenatal clinics in NI were eligible for inclusion. 
Data collection continued for 12 months.  
Pregnancy planning indicators and maternal and neonatal outcomes were abstracted 
from patient notes by a midwife using a service evaluation tool, which replicated the 
audit tool used for the historical cohort.  In addition the midwife inquired if the woman 
had received and viewed the DVD prior to conception, and the action they had taken 
as a consequence of watching the DVD. 
Baseline comparison data were available from a regional audit of the same five 
regional joint diabetes-antenatal clinics across NI, involving all deliveries/expected 
deliveries in women with pre-gestational diabetes between 1st September 2009 and 
31st August 2010 (pre-implementation of the DVD; pre-DVD comparison cohort). 
The primary outcome was HbA1c at first joint diabetes-antenatal clinic visit in women 
post implementation of the DVD (post-DVD cohort) compared with the pre-DVD cohort 
in an intention to treat analysis. Secondary outcomes comprised other indicators of 
pregnancy planning including: pre-pregnancy folic acid use, gestational age at first 
antenatal visit, record of HbA1c measured in 6 months prior to pregnancy and 
documented use of contraception prior to pregnancy. In addition pregnancy planning 
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indicators were compared between women who both received and viewed the DVD 
(viewed-DVD) and those prior to the DVD launch (pre-DVD cohort). Maternal and 
neonatal outcomes included early pregnancy loss, congenital malformations and 
stillbirths. As women with type 1 and type 2 diabetes are at similar risk of poor 
pregnancy outcomes, and given the small numbers of women with type 2 diabetes in 
our population, analysis was carried out on all women with diabetes, type 1 and type 
2 combined. Deprivation scores were obtained from the postcode of residence using 
the NI Multiple Deprivation Measure based on geographical area of residence to reflect 
socio-economic status [22]. Social deprivation scores were then divided into quintiles 
with women in the bottom quintile considered to be most socially deprived.   
 
Statistical analysis 
A sample size of 200 (100 in each of the pre- and post-DVD cohorts) was required to 
give an excess of 95% power to detect a 0.5% (or 5.5 mmol/mol) difference in mean 
HbA1c between cohorts as statistically significant (P<0.05; two-tailed), assuming an 
inter-patient SD in HbA1c of 0.95% (or 10.4 mmol/mol) as observed in a similar 
population [23]. Assuming that 45% of the comparison cohort took folic acid pre-
conception [23], the study size had  in excess of 80% power to detect a difference 
of 20% (e.g. an increase from 45% to 65% taking folic acid pre-conception) as 
statistically significant (P<0.05; two-tailed). 
 
Comparisons between the comparison cohort (pre-DVD) and study cohort (post-DVD 
or viewed-DVD) were carried out using Chi-square or Fisher exact tests for categorical 
variables and two-tailed Student’s t test for continuous variables. Logistic regression 
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(categorical variables) and multiple regression (continuous variables) were used to 
adjust these comparisons for diabetes type, diabetes duration, parity, social 
deprivation, age and booking hospital. Results were considered statistically significant 
at the 5% level.  
 
RESULTS 
Maternal Characteristics  
In total, 135 women were included in the post DVD evaluation (post-DVD cohort), and 
114 women from the baseline regional audit served as the comparison cohort (pre-
DVD cohort). Characteristics of the women before and after the DVD launch are shown 
in Table 1. Women pre and post DVD launch were similar in age, ethnicity, social 
deprivation, BMI, diabetes duration and 1st  joint antenatal-metabolic clinic visit clinical 
measures, but there were significantly fewer nulliparous women in the post-DVD 
cohort.  
 
Pregnancy planning indicators 
Pregnancy planning indicators of women before and after DVD distribution, and of the 
subgroup of women who both received and viewed the DVD prior to their pregnancy 
are shown in Table 2. There was a non-significant reduction in mean HbA1c at the 1st 
joint antenatal-metabolic clinic post-DVD compared to pre-DVD.  Post-DVD, women 
were significantly more likely to have had HbA1c recorded in the 6 months 
preconception and there were also indications of improved pregnancy planning; 
women were more likely to have reported that the pregnancy was planned and to have 
taken folic acid preconception. Post-DVD, women were less likely to have a record in 
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their antenatal notes that they attended for or received pre-pregnancy counselling, 
however this was no longer significant when adjusted for confounding variables.  
 
Effectiveness of distribution programme  
While 62% of women reported receiving the DVD, 43% reported viewing the DVD prior 
to conception (viewed-DVD subgroup), with a larger proportion of women with type 1 
diabetes receiving and viewing the DVD as outlined in figure 1.  
 
Comparison of viewed-DVD subgroup to pre-implementation data 
Characteristics of the viewed-DVD subgroup are shown in Table 1.  Of those women 
who viewed the DVD, 22% were already attending for PPC, 36% proceeded to contact 
either their Diabetes Care Team or GP for PPC while 33% made lifestyle changes 
based on the advice given in the DVD but did not seek professional advice. Only 9% 
did not make changes or seek advice before pregnancy. The viewed-DVD subgroup 
had significantly lower HbA1c at the 1st antenatal-metabolic visit compared with the 
baseline comparator pre-DVD cohort as shown in Table 2. Compared with the pre-
DVD cohort, the viewed-DVD subgroup were also significantly more likely to have 
planned their pregnancy (P=0.001), to have taken folic acid preconception (P<0.001), 
to have an HbA1c recorded in the 6 months prior to pregnancy (P<0.001), to have an 
HbA1c below 7.0% or 53mmol/mol (P<0.05) at the first visit and to be a current non-
smoker (P<0.05). A similar proportion of women who viewed the DVD had a record of 
receiving pre-pregnancy counselling in their antenatal records as in the pre-DVD 
period. 
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Pregnancy progress and outcomes 
Pregnancy progress and outcome indicators, before and after the DVD launch, 
including the subgroup of women who viewed the DVD prior to pregnancy are outlined 
in Table 3. Significant differences in glycemic control between the pre- and post-DVD 
cohorts were only evident in the 3rd trimester, most likely as a reflection of improved 
diabetes care during pregnancy.  However, improved glycemic control in the 1st 
trimester was evident in the viewed-DVD subgroup compared with the pre-DVD cohort 
which may indicate improvement in pregnancy planning among those women who 
viewed the DVD.  
 
Post-DVD significantly fewer women experienced fetal loss (miscarriage, termination 
of pregnancy or late fetal loss) compared to the pre-DVD cohort (14% vs. 4.4%), with 
the miscarriage/late fetal loss rate further reduced to 1.7% in the viewed-DVD 
subgroup. There were no stillbirths in the post-DVD cohort, compared with 3 (2.6%) in 
the pre-DVD cohort. There was one neonatal death in the post-DVD cohort. There was 
no significant difference between any of the cohorts for any other indicators of 
pregnancy progress or for any other maternal or neonatal outcomes.  
  
 
 
 
DISCUSSION 
The current study evaluates  the implementation of an innovative DVD preconception 
counselling resource for women with diabetes into routine healthcare in NI. While 
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mean HbA1c at the first antenatal-metabolic visit was lower in the post-DVD cohort 
compared with the pre-DVD cohort, this did not reach statistical significance.  
However, women in the post-DVD cohort were significantly less likely to experience 
fetal loss which included miscarriage, termination of pregnancy and late fetal loss. For 
those women who viewed the DVD prior to conception, there was some evidence of 
enhanced pregnancy planning as indicated by improved glycemic control and folic acid 
uptake. Furthermore, the vast majority of women indicated that they made positive 
pregnancy planning decisions after viewing the resource, either by contacting a 
healthcare professional for PPC or actively making positive lifestyle changes. 
 
While the impact of the resource on adverse pregnancy outcomes in this study is 
limited, demonstration of an effect was made difficult by the limited numbers of women 
and pragmatic nature of the study.  In addition, our overall  findings are  in keeping 
with those of Willhoite and colleagues [24]  who developed a programme to highlight 
the importance of preconception counselling to healthcare providers and women with 
diabetes in Maine, USA, in a region where only 34% of 185 pregnancies occurred in 
women who had received counselling. In addition, Pearson and colleagues [7]  have 
previously reported on the benefits of planning pregnancy and formal pre-pregnancy 
care in relation to a similar composite adverse pregnancy outcome in women with type 
1 diabetes. Tripahti and colleagues [25] also found improved first trimester glycemic 
control in women receiving preconception counselling. In the present study, HbA1c 
was non-significantly lower in the post-DVD cohort, however, this reduction reached 
significance in those who viewed the DVD. The positive impact of the implementation 
of the DVD into routine care on foetal loss is likely be a reflection of the comprehensive 
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nature of pregnancy planning, and the fact that planning advice goes beyond glycemic 
control to include advice on folic acid supplementation, medications and lifestyle.  
 
Prior to the DVD launch, we successfully evaluated the DVD among women with 
diabetes and reported the effectiveness of the DVD in increasing knowledge and 
enhancing attitudes of women with diabetes to PPC [20]. While similar findings of 
effectiveness have been reported for a preconception counselling resource aimed at 
adolescents in the US [26], the longer term impact on pregnancy planning in that 
cohort remains unknown as no pregnancies have yet been reported.  
A particular strength of this study is the evaluation of the resource over a longer period 
using a population based approach, where the impact on pregnancy planning 
indicators in a subsequent pregnancy  is explored. This study encompasses a large 
geographic region and captured maternal and neonatal outcomes for all women with 
diabetes delivering in the region, allowing an extensive evaluation of distribution and 
uptake of this resource.  
 
However, our study has a number of limitations. It was not possible to determine which 
women also benefited from structured PPC, and antenatal records of pre-pregnancy 
counselling are likely to be a mixture of preconception counselling and structured PPC. 
In addition, the majority of women in this study were of white ethnicity, reflecting the 
background population of Northern Ireland, making the findings of this study 
generalizable to white populations. While data collection methodology was carefully 
repeated from pre to post audit it is well known that capture of early miscarriage in 
secondary care is difficult as some women may have miscarried before attendance at 
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the first diabetes-antenatal clinic. Finally, we acknowledge that a randomised 
controlled trial would have been the ideal study design to fully determine effectiveness 
of the DVD. However, as initial feasibility work determined that it was not feasible to 
carry out a regional RCT within the primary care setting, and thus to reach as many 
women with diabetes as possible throughout the region, irrespective of pregnancy 
plans, the current study design was chosen. The authors acknowledge that a major 
limitation of the design is that the observed changes may have occurred for other 
reasons than having seen the DVD. Nonetheless, the findings of this evaluation 
indicate that implementation of the DVD had a positive impact on outcomes, and that 
viewing the DVD is associated with improved pregnancy planning indicators, 
regardless of process. 
 
Despite a targeted distribution campaign, our study shows that reaching all women 
with diabetes, particularly those with type 2 diabetes, remains a challenge. This is in 
keeping with other studies where pre-pregnancy care rates were lower in women with 
type 2 diabetes [16,25,27]. In our study only 34% of GP practices actively engaged 
with the distribution programme, in contrast to all diabetes care teams. As GPs are 
often the sole providers of diabetes care in type 2 diabetes, our study highlights the 
urgent need for primary care to further engage in preconception counselling for women 
with diabetes, especially those with type 2 diabetes. A recent study reported that GPs 
and secondary care professionals differ in their perception of the number of women 
with diabetes requiring preconception care and regarding the role of GPs in that care 
[28]. A greater awareness of the importance of preconception counselling is needed 
and all healthcare professionals must avail of every opportunity to have that 
‘conversation’ with women.  A resource such as this DVD is an ideal tool to assist 
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healthcare professionals in offering preconception counselling to women with 
diabetes. In this resource roll-out, 30% of those women who said they received the 
DVD did not watch it.  To maximise impact and reach, and address non-engagement 
with the resource the Women with Diabetes project team have subsequently converted 
the DVD to a mobile friendly website (www.womenwithdiabtes.net) [29], which now 
includes an e-learning continuing professional development resource for healthcare 
professionals. Finally, women who viewed the DVD were also less likely to come from 
a deprived background, again in keeping with other studies [16,25], and further 
highlighting the continuing need to develop novel approaches to reach socially 
deprived communities.  
 
This regional evaluation of the implementation of a preconception counselling 
resource for women with diabetes into routine care demonstrates improved pregnancy 
planning indicators post implementation.. While challenges remain to engage women, 
those who viewed the resource were better prepared for pregnancy in terms of 
glycemic control and folic acid uptake. Our findings also highlight the ongoing 
challenges of reaching all women with diabetes, in particular those with type 2 diabetes 
and those from socially deprived backgrounds. Future programmes need to consider 
a joint approach between primary and secondary care services to increase reach of 
educational resources and hence maximize benefit for all women with diabetes. 
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Table 1. Characteristics of pregnant women with diabetes in Northern Ireland before and after the DVD launch, and of the 
subgroup of women who viewed the DVD prior to their pregnancy 
 Pre DVD  
(N = 114 ) 
Post DVD  
(N = 135) 
P value* Viewed DVD  
(N = 58) 
P value** 
Age, yr, mean (SD) [n] 30.9 (6.5) [114] 31.3 (5.6) [135] 0.60 32.0 (4.7) [58] 0.23 
White ethnicity, n/N (%) 111/114 (97.4) 129/135 (95.6) 0.51 56/58 (96.6) 1.00 
Type of Diabetes, n/N (%) 
Type 1 
Type 2 
 
88 (77.2) 
26 (22.8) 
 
95 (70.4) 
40 (29.6) 
 
0.22 
 
50 (86.2) 
8 (13.8) 
 
0.16 
Deprivation category, n/N (%) 
1  (most deprived) 
2 
3 
4 
5 (least deprived) 
 
31/114 (27.2) 
27/114 (23.7) 
28/114 (24.6) 
17/114 (14.9) 
11/114 (9.6) 
 
28/134 (20.9) 
23/134 (17.2) 
31/134 (23.1) 
29/134 (21.6) 
23/134 (17.2) 
 
0.02 † 
 
 
7/57 (12.3) 
9/57 (15.8) 
15/57 (26.3) 
12/57 (21.1) 
14/57 (24.6) 
 
0.001† 
Nulliparous, n/N (%) 52/114 (45.6) 44/135 (32.6) 0.035 23/58 (39.7) 0.46 
Diabetes duration, yr, mean (SD) [n] 12.0 (8.5) [113] 12.1 (8.7) [135] 0.94 15.6 (8.8) [58] 0.01 
BMI at booking, kg/m2, mean (SD) [n] 28.2 (5.7) [102] 28.8 (6.9) [133] 0.44 26.7 (5.0) [58] 0.11 
Overweight /Obese (BMI >=25kg/m2) at 
booking, n/N (%) 
65/102 (63.7) 86/133 (64.7) 0.88 31/58 (53.4) 0.20 
Data are mean (standard deviation) or n/N (%) unless otherwise stated. *Pre DVD vs. Post DVD; ** Pre DVD vs. Watched DVD; Comparisons made 
using the Student’s t–test for continuous variables and the chi-squared test for categorical variables. †Chi-squared test for trend.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
 
 
 
Table 2. Pregnancy planning indicators of women with diabetes in Northern Ireland before and after the DVD launch, and of the subgroup 
of women who viewed the DVD prior to their pregnancy  
 Pre DVD  
(N = 114 ) 
Post DVD  
(N = 135) 
Mean difference or 
Odds ratio (95%CI)  
     unadjusted* 
     adjusted† 
P 
value 
Viewed DVD 
 (N = 58) 
Mean difference or  
Odds ratio (95%CI)    
     unadjusted**  
     adjusted† 
P 
value 
Planned pregnancy 63/106 (59.4) 86/133 (64.7) 1.25 (0.74, 2.11) 
1.25 (0.68, 2.31)  
0.41 
0.48 
49/56 (87.5) 4.78 (1.98, 11.54)  
4.48 (1.55, 12.96)  
0.001 
0.006 
Record in antenatal notes of 
attending /receiving pre-pregnancy 
counselling 
41/113 (36.3) 32/134 (23.9) 0.55 (0.32, 0.96)  
0.58 (0.32, 1.05)  
0.03 
0.07 
23/57 (40.4) 1.19 (0.62, 2.28)  
1.05 (0.51, 2.10)  
0.61 
0.89 
Gestational age at 1st visit to joint 
antenatal-metabolic clinic, weeks 
 8.3 (3.2) 
[109] 
 
8.8 (3.3) [134] 
 
0.6 (-0,2, 1.4) 
0.5 (-0.3, 1.4) 
0.17 
0.22 
8.3 (2.3) [58] 
 
0.0 (-0.9, 1.0) 
0.1 (-0.9, 1.1) 
0.97 
0.90 
Taking folic acid preconception 47/111 (42.3) 
 
65/134 (48.5) 
 
1.28 (0.77, 2.13)  
1.33 (0.71, 2.47)  
0.34 
0.38 
46/57 (80.7) 
 
5.61 (2.63, 11.97)  
4.85 (1.94, 12.11)  
<0.001 
0.001 
Taking 5mg folic acid preconception 
(where dose recorded) 
21/28 (75.0) 
 
47/55 (85.5) 
 
1.96 (0.63, 6.10)  
2.14 (0.53, 8.68)  
0.26 
0.29 
38/41 (92.7) 
 
4.22 (0.99, 18.07)  
6.39 (0.93, 44.07)  
0.05 
0.06 
Documentation of contraceptive use 
before pregnancy 
48/108 (44.4) 
 
52/132 (39.4) 
 
0.81 (0.49, 1.36)  
0.94 (0.54, 1.62)  
0.43  
0.81 
21/55 (38.2) 
 
0.77 (0.40, 1.50)  
0.80 (0.39, 1.67)  
0.45 
0.56 
HbA1c result recorded in 6 months 
prior to this pregnancy 
59/112 (52.7) 
 
101/134 (75.4) 
 
2.75 (1.60, 4.72)  
3.60 (1.95, 6.65)  
<0.001 
<0.001 
50/57 (87.7) 
 
6.42 (2.68, 15.37) 
9.72 (3.28, 28.77)  
<0.001 
<0.001 
Most recent HbA1c result in 6 months 
prior to this pregnancy, %  
Most recent HbA1c result in 6 months 
prior to this pregnancy, mmol/mol, 
8.2 (2.2) [59] 
 
66 (25) [59] 
 
7.8 (1.8) [102] 
 
62 (19) [102] 
 
-0.4 (-1.0, 0.2) 
-0.2 (-0.8, 0.3) 
-4 (-11, 3) 
-3 (-9, 4) 
0.21 
0.43 
0.21 
0.43 
7.3 (1.4) [51] 
 
57 (15) [51] 
 
-0.9 (-1.6, -0.1) 
-0.6 (-1.2, 0.1) 
-9 (-17, -2) 
-6 (-14, 2) 
0.02 
0.12 
0.02 
0.12 
1st HbA1c recorded at joint diabetes-
antenatal clinic, %  
1st HbA1c recorded at joint diabetes-
antenatal clinic, mmol/mol 
7.8 (1.6) [109] 
 
62 (18) [109] 
 
7.5 (1.6) [134] 
 
58 (17) [134] 
 
-0.3 (-0.7, 0.1) 
-0.2 (-0.6, 0.2) 
-3.5 (-7.9, 0.9) 
-1.7 (-6.1, 2.7) 
0.12 
0.44 
0.12 
0.44 
6.9 (0.9) [58] 
 
52 (10) [58] 
 
-0.9 (-1.3, -0.4) 
-0.8 (-1.2, -0.3) 
-10 (-15, -5) 
-8 (-13, -3) 
P<0.001 
P=0.001 
P<0.001 
P=0.001 
HbA1c < 7.0% (53.0 mmol/mol) at 1st 
antenatal clinic 
40/108 (37.0) 52/133 (39.1) 
 
1.09 (0.65, 1.84)  
0.93 (0.52, 1.67)  
0.74 
0.80 
31/57 (54.4) 2.03 (1.06, 3.89)  
1.72 (0.81, 3.67)  
0.03 
0.16 
Current smoker 
 
22/107 (20.6) 
 
29/127 (22.8) 
 
1.14 (0.61, 2.14)  
1.20 (0.58, 2.48)  
0.68 
0.62 
1/53 (1.9) 
 
0.07 (0.01, 0.57)  
0.08 (0.01, 0.72)  
0.01 
0.02 
Data are mean (standard deviation) [n] and mean difference (95%CI) or n/N (%) and odds ratio (95%CI). *Pre DVD vs. Post DVD; ** Pre DVD vs. 
Watched DVD; Comparisons made using the Student’s t–test for continuous variables and the chi-squared test for categorical variables. †Adjusted 
for diabetes type, diabetes duration, parity, deprivation, age, and booking hospital. 
Table 3. Pregnancy progress indicators and pregnancy outcomes of women with diabetes in Northern Ireland before and 
after the DVD launch, and of the subgroup of women who viewed the DVD prior to their pregnancy  
 Pre-DVD  
(N = 114) 
Post DVD  
(N = 135) 
Mean difference or  
Odds ratio (95%CI) 
     unadjusted* 
     adjusted† 
P value Viewed DVD  
(N = 58) 
Mean difference or 
Odds ratio (95%CI) 
     unadjusted* 
     adjusted† 
P value 
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Averaged 1st trimester 
HbA1c,  % 
Averaged 1st trimester 
HbA1c,   mmol/mol 
7.4 (1.4) 
 
58 (16) [99] 
7.3 (1.4) 
 
56 (15) [119] 
-0.1 (-0.5, 0.2) 
 0.0 (-0.3, 0.4) 
-2 (-6, 3) 
0 (-4, 5) 
0.46 
0.82 
0.46 
0.82 
6.7 (8.4) 
 
50 (8) [55] 
-0.7 (-1,1, -0.3) 
-0.5 (-0.9, -0.1) 
-8 (-12, -3) 
-6 (-10, -1) 
<0.001 
0.01 
<0.001 
0.01 
Averaged 2nd trimester 
HbA1c,  % 
Averaged 2nd trimester 
HbA1c,  mmol/mol 
6.5 (1.0) 
 
47 (11) [99] 
6.3 (0.8) 
 
46 (9) [126] 
-0.2 (-0.4, 0.1) 
-0.1 (-0.3, 0.1) 
-2 (-4, 1) 
-1 (-4, 2) 
0.21 
0.42 
0.21 
0.42 
6.1 (0.5) 
 
44 (6) [55] 
-0.4 (-0.7, -0.1) 
-0.3 (-0.6, 0.0) 
-3 (-7, -1) 
-3 (-7, 0) 
0.02 
0.04 
0.02 
0.04 
Averaged 3rd trimester 
HbA1c,  % 
Averaged 3rd trimester 
HbA1c,  mmol/mol 
6.6 (1.2) 
 
49 (13) [96] 
6.2 (0.7)  
 
45 (8) [122] 
-0.4 (-0.6, -0.1) 
-0.3 (-0.6, -0.1) 
-4 (-7, -1) 
-3 (-6, -1) 
0.004 
0.01 
0.004 
0.01 
6.1 (0.6) 
 
43 (6) [54] 
-0.5 (-0.8, -0.1) 
-0.4 (-0.7, -0.1) 
-5 (-9, -2) 
-4 (-8, -1) 
0.006 
0.02 
0.006 
0.02 
Last pre delivery HbA1c,  
  %  
Last pre delivery HbA1c, 
mmol/mol 
6.6 (1.2) 
 
49 (13) [96] 
6.3 (0.7) 
 
45 (8) [127] 
-0.4 (-0.6, -0.1) 
-0.3 (-0.6, -0.1) 
-4 (-7, -1) 
-4 (-6, -1) 
0.006 
0.02 
0.006 
0.02 
6.1 (0.6) 
 
44 (7) [55] 
-0.5 (-0.8, -0.2) 
-0.4 (-0.7, -0.1) 
-5 (-9, -2) 
-4 (-8, -1) 
0.004 
0.02 
0.004 
0.02 
Severe hypos requiring 
3rd party help 
18/101 
(17.8) 
16/131 (12.2) 0.64 (0.31, 1.33)  
0.67 (0.30, 1.50)  
0.23 
0.33 
8/56 (14.3) 
 
0.77 (0.31, 1.90)  
0.55 (0.19, 1.58)  
0.60 
0.87 
Miscarriage/TOP/late 
foetal loss 
16/114 
(14.0) 
6/135 (4.4) 0.29 (0.11, 0.76) 
0.30 (0.11,0.82) 
0.01 
0.02 
1/58 (1.7) 
 
0.11 (0.01, 0.83)  
0.09 (0.01, 0.74)  
0.01 
0.02 
Major Malformation 2/94 (2.1) 5/128 (3.9) 1.87 (0.35-9.90) 
1.12 (0.17-7.41) 
0.45 
0.91 
2/57 (3.5) 1.67 (0.23-12.20) 
0.97 (0.10,9.35) 
0.61 
0.98 
Gestational age at birth, 
weeks 
36.9 (2.1) 
[96] 
36.8 (2.2) 
[129] 
-0.1 (-0.7, 0.5) 
-0.1 (-0.7, 0.5) 
0.72 
0.66 
37.2 (2.0) 
[57] 
0.3 (-0.4, 1.0) 
0.1 (-0.6, 0.9) 
0.39 
0.70 
Birth weight, grams 
 
3472 (582) 
[94] 
3361 (749) 
[129] 
-111 (-294, 71) 
-139 (-331, 54) 
0.21 
0.16 
3380 (784) 
[57] 
-92 (-313, 128) 
-142 (-378, 94) 
0.41 
0.24 
Macrosomia (> 4000 g)  
 
13/93 (14.0) 
 
26/128 (20.3) 
 
1.57 (0.76, 3.25)  
1.59 (0.72, 3.53)  
0.23 
0.26 
11/57 (19.3) 1.31 (0.65, 2.67)  
1.83 (0.80, 4.19)  
0.15 
0.45 
Vaginal delivery 27/96 (28.1) 
 
42/126 (33.3) 
 
1.28 (0.72, 2.28)  
1.42 (0.75, 2.68)  
0.41 
0.28 
19/56 (33.9) 0.76 (0.36, 1.58)  
0.73 (0.32, 1.67)  
0.46 
0.46 
Baby admitted to 
neonatal unit 
30/92 (32.6)  
 
35/127 (27.6) 
 
0.79 (0.44, 1.41)  
0.75 (0.39, 1.42)  
0.42 
0.38 
15/56 (26.8) 2.29 (0.98, 5.35)  
2.12 (0.83, 5.37)  
0.05 
0.12 
Exclusive breastfeeding 
on discharge 
12/87 (13.8) 
 
20/125 (16.0) 
 
1.19 (0.55, 2.58)  
1.26 (0.55, 2.86) 
0.66 
0.59 
15/56 (26.8) 2.06 (0.60, 7.11)  
1.84 (0.44, 7.68)  
0.25 
0.40 
Data are mean (standard deviation) [n] and mean difference (95%CI) or n/N (%) and odds ratio (95%CI). TOP is termination of pregnancy. *Pre 
DVD vs. Post DVD; ** Pre DVD vs. Viewed DVD; Comparisons made using the students t–test for continuous variables and the chi-squared test 
for categorical variables. †Adjusted for diabetes type, diabetes duration parity, social deprivation, age, and booking hospital. 
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Figure 1. Flow Chart of Resource Adoption, Recruitment and Service Evaluation. 
 
 
 
*Pre DVD cohort of women with Type 1 diabetes (T1D) and Type 2 diabetes (T2D) who delivered/expected to deliver between 01 September 2009 and 
31 August 2010. 
**Post DVD comparison cohort of women with T1D and T2D who delivered/expected to deliver between 01 February 2012 and 31 January 2013 
†64% of women in the Post DVD cohort reported receiving the DVD (n=84: 70, T1D 14, T2D) 
Pre DVD cohort* 
Sept ‘09 to Aug ’10 
n=114  
(88, T1D; 26 T2D) 
Post DVD cohort** 
Feb ‘12 to Jan ’13 
 n=135 
(95, T1D; 40 T2D) 
Distribution and adoption of the preconception counselling resource (6029 DVDs) into routine care in 
Northern Ireland:  
- 4710 copies of the DVD distributed via all diabetes care teams in the five health and 
social care trusts for distribution to women with diabetes 
- 1080 copies of the DVD requested by 34% of all general practices (125/364) for 
distribution to women with diabetes 
- 239 copies of the DVD sent to general practices (1 per practice) who did not respond 
to the invitation to adopt the resource 
 
DVD 
Distribution 
Viewed DVD subgroup† 
n=58  
(50, T1D; 8 T2D) 
 
